Cargando…
Clear Cell Renal Cell Carcinoma is linked to Epithelial‐to‐Mesenchymal Transition and to Fibrosis
Clear cell renal cell carcinoma (ccRCC) represents the most common type of kidney cancer with high mortality in its advanced stages. Our study aim was to explore the correlation between tumor epithelial‐to‐mesenchymal transition (EMT) and patient survival. Renal biopsies of tumorous and adjacent non...
Autores principales: | Landolt, Lea, Eikrem, Øystein, Strauss, Philipp, Scherer, Andreas, Lovett, David H., Beisland, Christian, Finne, Kenneth, Osman, Tarig, Ibrahim, Mohammad M., Gausdal, Gro, Ahmed, Lavina, Lorens, James B., Thiery, Jean Paul, Tan, Tuan Zea, Sekulic, Miroslav, Marti, Hans‐Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471444/ https://www.ncbi.nlm.nih.gov/pubmed/28596300 http://dx.doi.org/10.14814/phy2.13305 |
Ejemplares similares
-
AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction
por: Landolt, Lea, et al.
Publicado: (2019) -
Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development
por: Eikrem, Oystein, et al.
Publicado: (2016) -
Expanding the Utilization of Formalin-Fixed, Paraffin-Embedded Archives: Feasibility of miR-Seq for Disease Exploration and Biomarker Development from Biopsies with Clear Cell Renal Cell Carcinoma
por: Strauss, Philipp, et al.
Publicado: (2018) -
AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease
por: Nakken, Sigrid, et al.
Publicado: (2021) -
Axl‐inhibitor bemcentinib alleviates mitochondrial dysfunction in the unilateral ureter obstruction murine model
por: Hoel, August, et al.
Publicado: (2021)